Toronto, Canada
Specific Biologics
$35.0M
Series A
Summary
Specific Biologics raised US$35 million in financing. Specific Biologics is a precision gene-editing therapy developer.
Investors
Hatteras Venture Partners, Lumira Ventures, adMare BioInnovations, Genesys Capital, BDC Life Sciences Venture Fund, DeepWork Capital, Seido Capital